Judith van Deutekom - Vice-President Drug Discovery

Judith van Deutekom, Vice-President Drug Discovery is a molecular biologist and has an extensive 17-year track record in the genetic research of muscular dystrophies. She has been dedicated to the development of a genetic therapy for Duchenne Muscular Dystrophy (DMD) since her postdoctoral studies at the University of Leiden (The Netherlands) and the University of Pittsburgh Medical Center (Pennsylvania, USA). She was awarded for her research on antisense oligoribonucleotides as small molecule drugs for DMD by the Princess Beatrix fund in 2001 and by the LUMC (C.J. Kok Award) in 2003.

Profile Image